首页 | 官方网站   微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   218篇
  免费   9篇
  国内免费   11篇
医药卫生   238篇
  2023年   1篇
  2022年   1篇
  2021年   3篇
  2020年   1篇
  2019年   6篇
  2018年   5篇
  2016年   4篇
  2015年   5篇
  2014年   4篇
  2013年   6篇
  2012年   3篇
  2011年   2篇
  2010年   8篇
  2009年   7篇
  2008年   6篇
  2007年   7篇
  2006年   3篇
  2005年   4篇
  2004年   5篇
  2003年   3篇
  2002年   1篇
  2001年   1篇
  2000年   3篇
  1999年   5篇
  1998年   8篇
  1997年   11篇
  1996年   9篇
  1995年   8篇
  1994年   11篇
  1993年   13篇
  1992年   2篇
  1991年   3篇
  1990年   4篇
  1989年   8篇
  1988年   7篇
  1987年   10篇
  1986年   10篇
  1985年   4篇
  1984年   1篇
  1983年   2篇
  1982年   2篇
  1981年   3篇
  1980年   4篇
  1979年   3篇
  1978年   7篇
  1977年   10篇
  1976年   3篇
  1963年   1篇
排序方式: 共有238条查询结果,搜索用时 15 毫秒
61.
62.
The first documented case of endometrial adenosarcoma associated with chronic tamoxifen usage is reported.  相似文献   
63.
64.
Supratentorial ependymoma: CT appearance   总被引:5,自引:0,他引:5  
The computed tomographic appearances of 22 biopsy-proved supratentorial ependymomas were analyzed. Supratentorial ependymomas were usually intraparenchymal, larger than 4 cm, and cystic. Contrast enhancement was moderate to intense, with homogeneous or ring-enhancement patterns commonly seen. Intratumoral calcification was present in one-third of the cases, while hydrocephalus and peritumoral edema were seen in 50%. Intratumoral hemorrhage was not a characteristic of the lesion. In contrast to cellular ependymomas, malignant ependymomas and ependymoblastomas demonstrate higher attenuation prior to administration of contrast material, more intense enhancement, lower frequency of calcification within the tumor, and less distinct margination.  相似文献   
65.
66.
The palliative radiotherapeutic management of unresectable non‐small‐cell lung cancer is controversial, with various fractionation (Fx) schedules available. We aimed to determine patient’s choice of Fx schedule after involvement in a decision‐making process using a decision board. A decision board outlining the various advantages and disadvantages apparent in the Medical Research Council study of Fx schedules (17 Gy in two fractions vs 39 Gy in 13 fractions) was discussed with patients who met Medical Research Council eligibility criteria. Patients were then asked to indicate their preferred Fx schedules, reasons and their level of satisfaction with being involved in the decision‐making process. Radiation oncologists (RO) could prescribe radiotherapy schedules irrespective of patients’ preferences. Of 92 patients enrolled, 55% chose the longer schedule. English‐speaking patients were significantly more likely to choose the longer schedule (P = 0.02, 95% confidence interval: 1.2–7.6). Longer Fx was chosen because of longer survival (90%) and better local control (12%). Shorter Fx was chosen for shorter overall treatment duration (80%), cost (61%) and better symptom control (20%). In all, 56% of patients choosing the shorter schedule had their treatment altered by the treating RO, whereas only 4% of patients choosing longer Fx had their treatment altered (P < 0.001). Despite this, all (100%) patients were satisfied with being involved in the decision‐making process. The decision board was useful in aiding decision‐making, with both Fx schedules being acceptable to patients. Interestingly, despite the longer average survival associated with longer Fx, nearly half of the patients believed that this was not as important as a shorter duration of treatment and lower cost. Despite patients’ preferences, there were significant alterations of preferred schedules because of RO’s own biases.  相似文献   
67.
68.
69.
70.
Kumar  AJ; Naidich  TP; George  AE; Lin  JP; Kricheff  II 《Radiology》1978,126(2):431-439
The choroidal artery to the fourth ventricle has been studied in 25 brain specimens and 100 normal posterior fossa angiograms, including 25 angiotomograms. Its variable origin, course and radiological significance have been stressed.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号